​

Elicio Therapeutics (ELTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ELTX Stock Forecast

Elicio Therapeutics (ELTX) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $11.83, with a high of $17.00 and a low of $1.50. This represents a 683.44% increase from the last price of $1.51.

- $4 $8 $12 $16 $20 High: $17 Avg: $11.83 Low: $1.5 Last Closed Price: $1.51

ELTX Stock Rating

Elicio Therapeutics stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

ELTX Price Target Upside V Benchmarks

TypeNameUpside
StockElicio Therapeutics683.44%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$17.00
Last Closing Price$1.51$1.51$1.51
Upside/Downside--1025.83%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 26-31--4
Oct, 26-31--4
Sep, 26-31--4
Aug, 26-31--4
Jul, 26-31--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 13, 2026Robert BurnsH.C. Wainwright$17.00$10.9055.96%1025.83%
Jun 30, 2022Annabel SamimyStifel Nicolaus$1.50$1.71-12.28%-0.66%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 18, 2026H.C. WainwrightBuyBuyhold
Jun 15, 2026Rodman & RenshawBuyBuyhold
Jun 15, 2026H.C. WainwrightBuyBuyhold
Jun 10, 2026B. RileyBuyinitialise
Mar 13, 2026H.C. WainwrightBuyBuyhold
Mar 09, 2026Rodman & RenshawBuyinitialise

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-19.32$-9.10$-6.96$-4.25$-2.58---
Avg Forecast$-28.10$-12.90$-2.53$-4.07$-2.94$-2.40$-1.24$-1.14
High Forecast$-28.10$-12.90$-1.60$-3.77$-2.54$-2.40$-1.24$-1.14
Low Forecast$-28.10$-12.90$-3.46$-4.35$-3.33$-2.40$-1.24$-1.14
Surprise %-31.25%-29.46%175.10%4.42%-12.24%---

Revenue Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$28.31M-------
Avg Forecast$9.79M$2.30M---$20.00M--
High Forecast$9.79M$2.30M---$20.00M--
Low Forecast$9.79M$2.30M---$20.00M--
Surprise %189.24%-------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-26.40M$-28.21M$-35.20M$-51.90M$-39.57M---
Avg Forecast$-142.08M$-65.23M$-12.79M$-20.53M$-14.84M$-12.13M$-6.27M$-5.76M
High Forecast$-142.08M$-65.23M$-8.11M$-19.08M$-12.85M$-12.13M$-6.27M$-5.76M
Low Forecast$-142.08M$-65.23M$-17.47M$-21.98M$-16.84M$-12.13M$-6.27M$-5.76M
Surprise %-81.42%-56.75%175.13%152.83%166.57%---

ELTX Forecast FAQ

Is Elicio Therapeutics stock a buy?

Elicio Therapeutics stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Elicio Therapeutics is a favorable investment for most analysts.

What is Elicio Therapeutics's price target?

Elicio Therapeutics's price target, set by 4 Wall Street analysts, averages $11.83 over the next 12 months. The price target range spans from $1.5 at the low end to $17 at the high end, suggesting a potential 683.44% change from the previous closing price of $1.51.

How does Elicio Therapeutics stock forecast compare to its benchmarks?

Elicio Therapeutics's stock forecast shows a 683.44% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Elicio Therapeutics over the past three months?

  • November 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Elicio Therapeutics’s EPS forecast?

Elicio Therapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.4, marking a -6.98% decrease from the reported $-2.58 in 2025. Estimates for the following years are $-1.24 in 2027, and $-1.14 in 2028.

What is Elicio Therapeutics’s revenue forecast?

Elicio Therapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $20M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, and $0 for 2028.

What is Elicio Therapeutics’s net income forecast?

Elicio Therapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-12.135M, representing a -69.33% decrease from the reported $-39.571M in 2025. Projections indicate $-6.27M in 2027, and $-5.764M in 2028.